Literature DB >> 20153740

Abnormal gene expression in cerebellum of Npc1-/- mice during postnatal development.

Guanghong Liao1, Zhining Wen, Kristopher Irizarry, Ying Huang, Katherine Mitsouras, Mariam Darmani, Terry Leon, Leming Shi, Xiaoning Bi.   

Abstract

Niemann-Pick Type C (NPC) disease is an autosomal recessive neurodegenerative disorder with abnormal lipid storage as the major cellular pathologic hallmark. Genetic analyses have identified mutations in NPC1 gene in the great majority of cases, while mutations in NPC2 account for the remainders. Yet little is known regarding the cellular mechanisms responsible for NPC pathogenesis, especially for neurodegeneration, which is the usual cause of death. To identify critical steps that could account for the pathological manifestations of the disease in one of the most affected brain structures, we performed global gene expression analysis in the cerebellum from 3-week old Npc1+/+ and Npc1-/- mice with two different microarray platforms (Agilent and Illumina). Differentially expressed genes identified by both microarray platforms were then subjected to KEGG pathway analysis. Expression of genes in six pathways was significantly altered in Npc1-/- mice; functionally, these signaling pathways belong to the following three categories: (1) steroid and terpenoid biosynthesis, (2) immune response, and (3) cell adhesion/motility. In addition, the expression of several proteins involved in lipid transport was significantly altered in Npc1-/- mice. Our results provide novel molecular insight regarding the mechanisms of pathogenesis in NPC disease and reveal potential new therapeutic targets. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153740      PMCID: PMC2848886          DOI: 10.1016/j.brainres.2010.02.019

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  70 in total

1.  Molecular cloning of the mouse apolipoprotein D gene and its upregulated expression in Niemann-Pick disease type C mouse model.

Authors:  K Yoshida; E S Cleaveland; J W Nagle; S French; L Yaswen; T Ohshima; R O Brady; P G Pentchev; A B Kulkarni
Journal:  DNA Cell Biol       Date:  1996-10       Impact factor: 3.311

2.  NPC1-containing compartment of human granulosa-lutein cells: a role in the intracellular trafficking of cholesterol supporting steroidogenesis.

Authors:  H Watari; E J Blanchette-Mackie; N K Dwyer; G Sun; J M Glick; S Patel; E B Neufeld; P G Pentchev; J F Strauss
Journal:  Exp Cell Res       Date:  2000-02-25       Impact factor: 3.905

3.  T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture.

Authors:  J Satoh; Y B Lee; S U Kim
Journal:  Brain Res       Date:  1995-12-15       Impact factor: 3.252

4.  Identification of HE1 as the second gene of Niemann-Pick C disease.

Authors:  S Naureckiene; D E Sleat; H Lackland; A Fensom; M T Vanier; R Wattiaux; M Jadot; P Lobel
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

5.  Fate of endogenously synthesized cholesterol in Niemann-Pick type C1 cells.

Authors:  J C Cruz; T Y Chang
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

6.  Changes in the levels of dolichol and dolichyl phosphate in a murine model of Niemann-Pick's type C disease.

Authors:  S Schedin; P G Pentchev; U Brunk; G Dallner
Journal:  J Neurochem       Date:  1995-08       Impact factor: 5.372

Review 7.  The role of apolipoprotein E in the nervous system.

Authors:  K H Weisgraber; A D Roses; W J Strittmatter
Journal:  Curr Opin Lipidol       Date:  1994-04       Impact factor: 4.776

Review 8.  Surface proteins involved in T cell costimulation.

Authors:  A Mondino; M K Jenkins
Journal:  J Leukoc Biol       Date:  1994-06       Impact factor: 4.962

9.  Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D.

Authors:  S C Patel; K Asotra; Y C Patel; W J McConathy; R C Patel; S Suresh
Journal:  Neuroreport       Date:  1995-03-07       Impact factor: 1.837

Review 10.  Axonal control of oligodendrocyte development.

Authors:  B A Barres; M C Raff
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

View more
  17 in total

Review 1.  Do heterozygous mutations of Niemann-Pick type C predispose to late-onset neurodegeneration: a review of the literature.

Authors:  Susanne A Schneider; Sabina Tahirovic; John Hardy; Michael Strupp; Tatiana Bremova-Ertl
Journal:  J Neurol       Date:  2019-11-07       Impact factor: 4.849

2.  Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1.

Authors:  Stephanie M Cologna; Celine V M Cluzeau; Nicole M Yanjanin; Paul S Blank; Michelle K Dail; Stephan Siebel; Cynthia L Toth; Christopher A Wassif; Andrew P Lieberman; Forbes D Porter
Journal:  J Inherit Metab Dis       Date:  2013-05-08       Impact factor: 4.982

3.  Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.

Authors:  Celine V M Cluzeau; Dawn E Watkins-Chow; Rao Fu; Bhavesh Borate; Nicole Yanjanin; Michelle K Dail; Cristin D Davidson; Steven U Walkley; Daniel S Ory; Christopher A Wassif; William J Pavan; Forbes D Porter
Journal:  Hum Mol Genet       Date:  2012-05-22       Impact factor: 6.150

4.  Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration.

Authors:  Guanghong Liao; Zhuangjun Wang; Erik Lee; Stephanie Moreno; Omar Abuelnasr; Michel Baudry; Xiaoning Bi
Journal:  Exp Neurol       Date:  2015-04-09       Impact factor: 5.330

5.  Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology.

Authors:  Niamh X Cawley; Caitlin Sojka; Antony Cougnoux; Anna T Lyons; Elena-Raluca Nicoli; Christopher A Wassif; Forbes D Porter
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

6.  Toll-like receptor mediated lysozyme expression in Niemann-pick disease, type C1.

Authors:  Antony Cougnoux; Julia C Yerger; Mason Fellmeth; Jenny Serra-Vinardell; Christopher A Wassif; Niamh X Cawley; Forbes D Porter
Journal:  Mol Genet Metab       Date:  2020-10-18       Impact factor: 4.797

7.  Efficacy of N-acetylcysteine in phenotypic suppression of mouse models of Niemann-Pick disease, type C1.

Authors:  Rao Fu; Christopher A Wassif; Nicole M Yanjanin; Dawn E Watkins-Chow; Laura L Baxter; Art Incao; Laura Liscum; Rohini Sidhu; Sally Firnkes; Mark Graham; Daniel S Ory; Forbes D Porter; William J Pavan
Journal:  Hum Mol Genet       Date:  2013-05-10       Impact factor: 6.150

Review 8.  The Role of Geranylgeranyltransferase I-Mediated Protein Prenylation in the Brain.

Authors:  Shangfeng Gao; Rutong Yu; Xiuping Zhou
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

Review 9.  Genetic dissection of a cell-autonomous neurodegenerative disorder: lessons learned from mouse models of Niemann-Pick disease type C.

Authors:  Manuel E Lopez; Matthew P Scott
Journal:  Dis Model Mech       Date:  2013-08-01       Impact factor: 5.758

10.  Genomic expression analyses reveal lysosomal, innate immunity proteins, as disease correlates in murine models of a lysosomal storage disorder.

Authors:  Md Suhail Alam; Michelle Getz; Innocent Safeukui; Sue Yi; Pamela Tamez; Jenny Shin; Peter Velázquez; Kasturi Haldar
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.